The Platform

Septerna is a clinical-stage biotechnology company powered by our proprietary Native Complex Platform™  

What we do

Unlocking the full potential of GPCRs to build a deep pipeline of oral small molecule therapies

Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.

Ground-breaking science is at our core

Meet The Leaders

Leadership Team

Jeffrey Finer, MD, PhD

Jeffrey Finer, MD, PhD

Chief Executive Officer and Co-Founder

Liz Bhatt, MS, MBA

Liz Bhatt, MS, MBA

Chief Operating Officer

Samira Shaikhly

Samira Shaikhly

Chief People Officer

Jae Kim, MD

Jae Kim, MD

Chief Medical Officer

Uwe Klein, PhD

Uwe Klein, PhD

Senior Vice President, Biological Sciences

Daniel Long, DPhil

Daniel Long, DPhil

Senior Vice President, Drug Discovery

Ran Xiao, MBA, CFA

Ran Xiao, MBA, CFA

Interim Chief Financial Officer and Vice President of Finance and Business Operations

Meet The Directors

Board of Directors

Jeffrey Finer, MD, PhD

Chief Executive Officer and Co-Founder

Alan Ezekowitz, MD, DPhil

Director

Jeffrey Tong, PhD

Chairman of the Board

Abraham Bassan, MS

Director

Bernard Coulie, M.D., Ph.D., M.B.A.

Director

Jake Simson, PhD

Director

Shalini Sharp, MBA

Director

Meet The Founders

Scientific Founders

Jeffrey Finer, MD, PhD

Chief Executive Officer and Co-Founder

Robert Lefkowitz, MD

Founder

Arthur Christopoulos, PhD

Founder

Patrick Sexton, PhD, DSc

Founder

Careers

Join our team of drug hunters, GPCR experts, drug developers, and company builders

We have built a strong values-driven organization advancing cutting-edge science and relentlessly focused on developing a portfolio of impactful new medicines for patients with significant unmet needs.

Video Player